99 related articles for article (PubMed ID: 12618695)
1. Is the rationale for carotid angioplasty and stenting in patients excluded from NASCET/ACAS or eligible for ARCHeR justified?
Illig KA; Zhang R; Tanski W; Benesch C; Sternbach Y; Green RM
J Vasc Surg; 2003 Mar; 37(3):575-81. PubMed ID: 12618695
[TBL] [Abstract][Full Text] [Related]
2. Carotid endarterectomy in SAPPHIRE-eligible high-risk patients: implications for selecting patients for carotid angioplasty and stenting.
Mozes G; Sullivan TM; Torres-Russotto DR; Bower TC; Hoskin TL; Sampaio SM; Gloviczki P; Panneton JM; Noel AA; Cherry KJ
J Vasc Surg; 2004 May; 39(5):958-65; discussion 965-6. PubMed ID: 15111844
[TBL] [Abstract][Full Text] [Related]
3. Contemporary outcomes for carotid endarterectomy at a large community-based academic health center.
Long GW; Nuthakki V; Bove PG; Brown OW; Shanley CJ; Bendick PJ; Rimar S; Kitzmiller J; Zelenock GB
Ann Vasc Surg; 2007 May; 21(3):321-7. PubMed ID: 17368835
[TBL] [Abstract][Full Text] [Related]
4. Influence of NASCET/ACAS trial eligibility on outcome after carotid endarterectomy.
Lepore MR; Sternbergh WC; Salartash K; Tonnessen B; Money SR
J Vasc Surg; 2001 Oct; 34(4):581-6. PubMed ID: 11668308
[TBL] [Abstract][Full Text] [Related]
5. Thirty-day morbidity and mortality rates for carotid artery intervention by surgeons who perform both carotid endarterectomy and carotid artery angioplasty and stent placement.
Ecker RD; Lau T; Levy EI; Hopkins LN
J Neurosurg; 2007 Feb; 106(2):217-21. PubMed ID: 17410702
[TBL] [Abstract][Full Text] [Related]
6. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results.
Gray WA; Hopkins LN; Yadav S; Davis T; Wholey M; Atkinson R; Cremonesi A; Fairman R; Walker G; Verta P; Popma J; Virmani R; Cohen DJ;
J Vasc Surg; 2006 Aug; 44(2):258-68. PubMed ID: 16890850
[TBL] [Abstract][Full Text] [Related]
7. Transcervical carotid stenting with flow reversal is safe in octogenarians: a preliminary safety study.
Alvarez B; Ribo M; Maeso J; Quintana M; Alvarez-Sabin J; Matas M
J Vasc Surg; 2008 Jan; 47(1):96-100. PubMed ID: 18060727
[TBL] [Abstract][Full Text] [Related]
8. Safety of latest-generation self-expanding stents in patients with NASCET-ineligible severe symptomatic extracranial internal carotid artery stenosis.
Linfante I; Hirsch JA; Selim M; Schlaug G; Caplan LR; Reddy AS
Arch Neurol; 2004 Jan; 61(1):39-43. PubMed ID: 14732618
[TBL] [Abstract][Full Text] [Related]
9. Society for Vascular Surgery Vascular Registry evaluation of stent cell design on carotid artery stenting outcomes.
Jim J; Rubin BG; Landis GS; Kenwood CT; Siami FS; Sicard GA;
J Vasc Surg; 2011 Jul; 54(1):71-9. PubMed ID: 21458198
[TBL] [Abstract][Full Text] [Related]
10. Carotid Revascularization Using Endarterectomy or Stenting Systems (CaRESS) phase I clinical trial: 1-year results.
CaRESS Steering Committee
J Vasc Surg; 2005 Aug; 42(2):213-9. PubMed ID: 16102616
[TBL] [Abstract][Full Text] [Related]
11. High-risk carotid endarterectomy: fact or fiction.
Gasparis AP; Ricotta L; Cuadra SA; Char DJ; Purtill WA; Van Bemmelen PS; Hines GL; Giron F; Ricotta JJ
J Vasc Surg; 2003 Jan; 37(1):40-6. PubMed ID: 12514576
[TBL] [Abstract][Full Text] [Related]
12. Protected stent-assisted carotid angioplasty in symptomatic high-risk NASCET-ineligible patients.
Cohen JE; Umansky F; Rajz G; Ben-Hur T
Neurol Res; 2005; 27 Suppl 1():S59-63. PubMed ID: 16197826
[TBL] [Abstract][Full Text] [Related]
13. Modification of outcomes by lowering ischemic events after reconstruction of extracranial vessels (MOLIERE): an internet-based prospective study to evaluate and improve the effectiveness of carotid endarterectomy.
Nault P; Elkouri S; Daniel V; Blanchard ME; Okrainec K;
J Vasc Surg; 2008 Mar; 47(3):530-6. PubMed ID: 18295104
[TBL] [Abstract][Full Text] [Related]
14. Outcome of carotid artery stenting for primary versus restenotic lesions.
Cuadra S; Hobson RW; Lal BK; Goldstein J; Chakhtoura E; Jamil Z
Ann Vasc Surg; 2009; 23(3):330-4. PubMed ID: 18692988
[TBL] [Abstract][Full Text] [Related]
15. Risk-adjusted 30-day outcomes of carotid stenting and endarterectomy: results from the SVS Vascular Registry.
Sidawy AN; Zwolak RM; White RA; Siami FS; Schermerhorn ML; Sicard GA;
J Vasc Surg; 2009 Jan; 49(1):71-9. PubMed ID: 19028045
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization.
Protack CD; Bakken AM; Xu J; Saad WA; Lumsden AB; Davies MG
J Vasc Surg; 2009 May; 49(5):1172-80.e1; discussion 1180. PubMed ID: 19394545
[TBL] [Abstract][Full Text] [Related]
17. Diabetes is not a predictor of outcome for carotid revascularization with stenting as it may be for carotid endarterectomy.
Parlani G; De Rango P; Cieri E; Verzini F; Giordano G; Simonte G; Isernia G; Cao P
J Vasc Surg; 2012 Jan; 55(1):79-89; discussion 88-9. PubMed ID: 22056251
[TBL] [Abstract][Full Text] [Related]
18. Carotid endarterectomy was performed with lower stroke and death rates than carotid artery stenting in the United States in 2003 and 2004.
McPhee JT; Hill JS; Ciocca RG; Messina LM; Eslami MH
J Vasc Surg; 2007 Dec; 46(6):1112-1118. PubMed ID: 18154987
[TBL] [Abstract][Full Text] [Related]
19. Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results.
White CJ; Iyer SS; Hopkins LN; Katzen BT; Russell ME;
Catheter Cardiovasc Interv; 2006 Apr; 67(4):503-12. PubMed ID: 16548004
[TBL] [Abstract][Full Text] [Related]
20. Carotid revascularization outcomes comparing distal filters, flow reversal, and endarterectomy.
Brewster LP; Beaulieu R; Corriere MA; Veeraswamy R; Niazi KA; Robertson G; Dodson TF; Kasirajan K
J Vasc Surg; 2011 Oct; 54(4):1000-4; discussion 1004-5. PubMed ID: 21871772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
